{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Radiographic+imaging&page=2", "query": { "intervention": "Radiographic imaging", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Radiographic+imaging&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T21:19:02.808Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02849496", "title": "Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage IV Breast Cancer AJCC v8", "Locally Advanced Unresectable Breast Carcinoma", "Metastatic Breast Carcinoma" ], "interventions": [ { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Olaparib", "type": "DRUG" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "X-Ray Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 89, "start_date": "2017-03-30", "completion_date": "2027-08-26", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 58, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • La Jolla, California + 43 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02849496" }, { "nct_id": "NCT05683964", "title": "Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Prostate Adenocarcinoma", "Prostate Cancer", "Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)" ], "interventions": [ { "name": "Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]", "type": "DRUG" }, { "name": "Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "MALE", "summary": "40 Years and older · Male only" }, "enrollment_count": 9, "start_date": "2023-01-19", "completion_date": "2026-09-01", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05683964" }, { "nct_id": "NCT02849171", "title": "Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Brain Cancer" ], "interventions": [ { "name": "PET scan", "type": "DEVICE" }, { "name": "C-Choline", "type": "RADIATION" } ], "intervention_types": [ "DEVICE", "RADIATION" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2016-07", "completion_date": "2022-05-06", "has_results": true, "last_update_posted_date": "2022-12-29", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02849171" }, { "nct_id": "NCT06062745", "title": "Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Prostate Cancer", "Metastatic Prostate Cancer", "Metastatic Prostate Neuroendocrine Carcinoma" ], "interventions": [ { "name": "18F-fluciclovine", "type": "DRUG" }, { "name": "PET/CT", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 30, "start_date": "2024-02-01", "completion_date": "2028-09-01", "has_results": false, "last_update_posted_date": "2025-11-05", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06062745" }, { "nct_id": "NCT06411795", "title": "Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Duodenal Neoplasm", "Pancreatic Neoplasm" ], "interventions": [ { "name": "Bupivacaine", "type": "DRUG" }, { "name": "Hydromorphone", "type": "DRUG" }, { "name": "Iopamidol", "type": "DRUG" }, { "name": "Liposomal Bupivacaine", "type": "DRUG" }, { "name": "Medical Chart Review", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Thoracic Epidural Analgesia", "type": "DRUG" }, { "name": "Ultrasound Imaging", "type": "PROCEDURE" }, { "name": "X-Ray Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 78, "start_date": "2023-11-10", "completion_date": "2028-01-01", "has_results": false, "last_update_posted_date": "2026-02-03", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06411795" }, { "nct_id": "NCT03941275", "title": "SelectSecure 3830 Lead Imaging", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Diseases" ], "interventions": [ { "name": "Bi-plane fluoroscopy", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Medtronic Cardiac Rhythm and Heart Failure", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2019-05-24", "completion_date": "2021-11-15", "has_results": false, "last_update_posted_date": "2022-03-15", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 4, "location_summary": "Huntsville, Alabama • West Des Moines, Iowa • Silver Spring, Maryland + 1 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "West Des Moines", "state": "Iowa" }, { "city": "Silver Spring", "state": "Maryland" }, { "city": "Voorhees Township", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03941275" }, { "nct_id": "NCT03195777", "title": "Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Deep Venous Thrombosis", "Post-thrombotic Syndrome" ], "interventions": [ { "name": "PET/CT", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 50, "start_date": "2017-12-20", "completion_date": "2025-06-27", "has_results": true, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03195777" }, { "nct_id": "NCT05805839", "title": "A Study of Imaging in Demyelinating Diseases", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Sclerosis", "Inflammatory Demyelinating Disease" ], "interventions": [ { "name": "C-11 ER176 Radiotracer", "type": "DRUG" }, { "name": "C11 Pittsburgh Compound B", "type": "DRUG" }, { "name": "PET/CT scan", "type": "DIAGNOSTIC_TEST" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2023-07-10", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05805839" }, { "nct_id": "NCT06636175", "title": "64Cu-LLP2A for Imaging Hematologic Malignancies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Multiple Myeloma", "Low-Grade Lymphoma", "Follicular Lymphoma", "Marginal Zone Lymphoma", "Lymphoplasmacytic Lymphoma", "Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia" ], "interventions": [ { "name": "64Cu-LLP2A", "type": "DRUG" }, { "name": "PET/CT", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2025-03-20", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06636175" }, { "nct_id": "NCT03123744", "title": "Histology-Independent Study of Palbociclib in Patients With Advanced Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer, Advanced" ], "interventions": [ { "name": "Palbociclib 125mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Razelle Kurzrock, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2018-07-01", "completion_date": "2024-02-01", "has_results": false, "last_update_posted_date": "2018-06-21", "last_synced_at": "2026-09-26T21:19:02.808Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03123744" } ] }